GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned an average rating of “Moderate Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $95.09.

Several equities analysts have issued reports on the company. Mizuho lifted their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Morgan Stanley upped their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Citigroup upped their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Finally, Argus increased their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st.

GE HealthCare Technologies Trading Up 0.3 %

Shares of GE HealthCare Technologies stock opened at $86.24 on Friday. GE HealthCare Technologies has a 12-month low of $62.35 and a 12-month high of $94.50. The stock has a market capitalization of $39.35 billion, a P/E ratio of 28.56, a price-to-earnings-growth ratio of 2.99 and a beta of 0.94. The company has a 50-day simple moving average of $88.92 and a 200 day simple moving average of $78.52. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $1.31 earnings per share. Research analysts expect that GE HealthCare Technologies will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after buying an additional 5,693,244 shares during the period. Norges Bank acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $229,052,000. Capital Research Global Investors boosted its stake in GE HealthCare Technologies by 2.8% during the 4th quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock worth $3,969,975,000 after acquiring an additional 1,401,566 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in GE HealthCare Technologies by 84.4% during the third quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company’s stock valued at $181,578,000 after purchasing an additional 1,221,436 shares during the period. Finally, Perpetual Ltd bought a new stake in GE HealthCare Technologies in the first quarter valued at approximately $96,135,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.